Lantern Pharma receives FDA clearance for pediatric brain cancer trial Mar 27, 2026 07:29AM
Lantern Pharma and Starlight Therapeutics Announce FDA Clearance of IND for a Planned Phase 1 Pediatric CNS Cancer Trial of STAR-001 Mar 27, 2026 07:29AM